FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 314:1465-1471 June 5, 1986 Number 23 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Within six hours after the onset of symptoms of myocardial infarction, we randomly assigned 1741 patients up to 75 years of age to a one-hour intravenous infusion of 1.5 million IU of streptokinase or placebo. At 21 days mortality was 6.3 percent in the streptokinase group and 7.1 percent in the placebo group. Of those treated within three hours of the onset of symptoms, 5.2 percent died in the streptokinase group (n = 477), as compared with 6.5 percent in the placebo group (n = 463). These differences were not significant. The time to peak serum levels of creatine kinase of myocardial origin (CK-MB) after the onset of symptoms was significantly shorter (13.9 vs. 19.2 hours), and the integrated area under the CK-MB curve (CK-MB infarct size) was significantly smaller, in the streptokinase group (P less than 0.02). Angiograms obtained in 848 patients three to four weeks after infarction revealed that the streptokinase group had higher global ejection fractions (56.8 vs. 53.9 percent, P less than 0.005) and regional ejection fractions (all patients in group, P less than 0.005; patients with anterior or inferior infarctions, P less than 0.05). We conclude that beginning intravenous streptokinase infusion early after the onset of myocardial infarction limits the size of the infarct regardless of its localization. There was, however, only a trend toward reduced mortality at 21 days.

This article has been cited by other articles:

• Reffelmann, T., Konemann, S., Kloner, R. A. (2009). Promise of Blood- and Bone Marrow-Derived Stem Cell Transplantation for Functional Cardiac Repair Putting It in Perspective With Existing Therapy.. J Am Coll Cardiol 53: 305-308 [Abstract] [Full Text]  
• Majidi, M., Kosinski, A. S., Al-Khatib, S. M., Lemmert, M. E., Smolders, L., van Weert, A., Reiber, J. H.C., Tzivoni, D., Bar, F. W.H.M., Wellens, H. J.J., Gorgels, A. P.M., Krucoff, M. W. (2008). Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias. Europace 10: 988-997 [Abstract] [Full Text]  
• Schulman, S., Beyth, R. J., Kearon, C., Levine, M. N. (2008). Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 257S-298S [Abstract] [Full Text]  
• Goodman, S. G., Menon, V., Cannon, C. P., Steg, G., Ohman, E. M., Harrington, R. A. (2008). Acute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 708S-775S [Abstract] [Full Text]  
• Bates, E. R. (2007). Role of Intravenous -Blockers in the Treatment of ST-Elevation Myocardial Infarction: Of Mice (Dogs, Pigs) and Men. Circulation 115: 2904-2906 [Full Text]  
• Fernandez-Aviles, F., Alonso, J. J., Pena, G., Blanco, J., Alonso-Briales, J., Lopez-Mesa, J., Fernandez-Vazquez, F., Moreu, J., Hernandez, R. A., Castro-Beiras, A., Gabriel, R., Gibson, C. M., Sanchez, P. L., for the GRACIA-2 (Grupo de Analisis de la Cardiopa, (2007). Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J 28: 949-960 [Abstract] [Full Text]  
• Gray, D (2006). Thrombolysis: past, present, and future.. Postgrad. Med. J. 82: 372-375 [Abstract] [Full Text]  
• Bunch, T. J., Hammill, S. C., White, R. D. (2005). Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival. Mayo Clin Proc. 80: 774-782 [Abstract]  
• Menon, V., Harrington, R. A., Hochman, J. S., Cannon, C. P., Goodman, S. D., Wilcox, R. G., Schunemann, H. J., Ohman, E. M. (2004). Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 549S-575S [Abstract] [Full Text]  
• Kloner, R. A., Rezkalla, S. H. (2004). Cardiac protection during acute myocardial infarction: Where do we stand in 2004?. J Am Coll Cardiol 44: 276-286 [Abstract] [Full Text]  
• Baker, W. F. Jr (2002). Thrombolytic Therapy. CLIN APPL THROMB HEMOST 8: 291-314  
• Soumerai, S. B., McLaughlin, T. J., Ross-Degnan, D., Christiansen, C. L., Gurwitz, J. H. (2002). Effectiveness of Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly: Cause for Concern in the Old-Old. Arch Intern Med 162: 561-568 [Abstract] [Full Text]  
• Carley, S D, Gamon, R, Driscoll, P A, Brown, G, Wallman, P (2002). What's the point of ST elevation?. Emerg. Med. J. 19: 126-128 [Abstract] [Full Text]  
• Dixon, S. R., Bartorelli, A. L., Marcovitz, P. A., Spears, R., David, S., Grinberg, I., Qureshi, M. A., Pepi, M., Trabattoni, D., Fabbiocchi, F., Montorsi, P., O'Neill, W. W. (2002). Initial experience with hyperoxemic reperfusion after primary angioplasty for acute myocardial infarction: Results of a pilot study utilizing intracoronary aqueous oxygen therapy. J Am Coll Cardiol 39: 387-392 [Abstract] [Full Text]  
• Yamamoto, K., Ito, H., Iwakura, K., Shintani, Y., Masuyama, T., Hori, M., Kawano, S., Higashino, Y., Fujii, K. (2001). Pressure-derived collateral flow index as a parameter of microvascular dysfunction in acute myocardial infarction. J Am Coll Cardiol 38: 1383-1389 [Abstract] [Full Text]  
• Schmitt, C., Lehmann, G., Schmieder, S., Karch, M., Neumann, F.-J., Schomig, A. (2001). Diagnosis of Acute Myocardial Infarction in Angiographically Documented Occluded Infarct Vessel : Limitations of ST-Segment Elevation in Standard and Extended ECG Leads. Chest 120: 1540-1546 [Abstract] [Full Text]  
• Ross, A. M., Molhoek, P., Lundergan, C., Knudtson, M., Draoui, Y., Regalado, L., Le Louer, V., Bigonzi, F., Schwartz, W., de Jong, E., Coyne, K. (2001). Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin: Second Trial of Heparin and Aspirin Reperfusion Therapy (HART II). Circulation 104: 648-652 [Abstract] [Full Text]  
• Priori, S.G., Aliot, E., Blomstrom-Lundqvist, C., Bossaert, L., Breithardt, G., Brugada, P., Camm, A.J., Cappato, R., Cobbe, S.M., Di Mario, C., Maron, B.J., McKenna, W.J., Pedersen, A.K., Ravens, U., Schwartz, P.J., Trusz-Gluza, M., Vardas, P., Wellens, H.J.J., Zipes, D.P. (2001). Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22: 1374-1450  
• Smith, S. C. Jr, Dove, J. T., Jacobs, A. K., Ward Kennedy, J., Kereiakes, D., Kern, M. J., Kuntz, R. E., Popma, J. J., Schaff, H. V., Williams, D. O., Gibbons, R. J., Alpert, J. P., Eagle, K. A., Faxon, D. P., Fuster, V., Gardner, T. J., Gregoratos, G., Russell, R. O., Smith, S. C. Jr (2001). ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 37: 2239-2239 [Full Text]  
• Boucher, J.-M., Racine, N., Thanh, T. H., Rahme, E., Brophy, J., LeLorier, J., Theroux, P. (2001). Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction. CMAJ 164: 1285-1290 [Abstract] [Full Text]  
• Ohman, E. M., Harrington, R. A., Cannon, C. P., Agnelli, G., Cairns, J. A., Kennedy, J.W. (2001). Intravenous Thrombolysis in Acute Myocardial Infarction. Chest 119 : 253S-277S [Full Text]  
• Saturno, P. J., Felices, F., Segura, J., Vera, A., Rodriguez, J. J., ARIAM Project Group, (2000). Reducing Time Delay in the Thrombolysis of Myocardial Infarction: An Internal Quality Improvement Project. American Journal of Medical Quality 15: 85-93 [Abstract]  
• Whan Lee, C., Park, S.-W., Cho, G.-Y., Hong, M.-K., Kim, J.-J., Kang, D.-H., Song, J.-K., Lee, H.-J., Park, S.-J. (2000). Pressure-derived fractional collateral blood flow: a primary determinant of left ventricular recovery after reperfused acute myocardial infarction. J Am Coll Cardiol 35: 949-955 [Abstract] [Full Text]  
• Klamann, A, Sarfert, P, Launhardt, V, Schulte, G, Schmiegel, W.H, Nauck, M.A (2000). Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide). Eur Heart J 21: 220-229 [Abstract]  
• Iqbal, O., Messmore, H., Hoppensteadt, D., Fareed, J., Wehrmacher, W. (2000). State-of-the-Art Review : Thrombolytic Drugs in Acute Myocardial Infarction. CLIN APPL THROMB HEMOST 6: 1-13  
• Gottlieb, S., Boyko, V., Harpaz, D., Hod, H., Cohen, M., Mandelzweig, L., Khoury, Z., Stern, S., Behar, S., for the Israeli Thrombolytic Survey Group, (1999). Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction. J Am Coll Cardiol 34: 70-82 [Abstract] [Full Text]  
• Franzosi, M. G., Santoro, E., De Vita, C., Geraci, E., Lotto, A., Maggioni, A. P., Mauri, F., Rovelli, F., Santoro, L., Tavazzi, L., Tognoni, G. (1998). Ten-Year Follow-Up of the First Megatrial Testing Thrombolytic Therapy in Patients With Acute Myocardial Infarction : Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 Study. Circulation 98: 2659-2665 [Abstract] [Full Text]  
• Kondo, M., Nakano, A., Saito, D., Shimono, Y. (1998). Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction. J Am Coll Cardiol 32: 898-903 [Abstract] [Full Text]  
• Baigent, C., Collins, R., Appleby, P., Parish, S., Sleight, P., Peto, R. (1998). ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. BMJ 316: 1337-1343 [Abstract] [Full Text]  
• Ross, A. M., Coyne, K. S., Moreyra, E., Reiner, J. S., Greenhouse, S. W., Walker, P. L., Simoons, M. L., Draoui, Y. C., Califf, R. M., Topol, E. J., Van de Werf, F., Lundergan, C. F. (1998). Extended Mortality Benefit of Early Postinfarction Reperfusion. Circulation 97: 1549-1556 [Abstract] [Full Text]  
• White, H. D., Van de Werf, F. J. J. (1998). Thrombolysis for Acute Myocardial Infarction. Circulation 97: 1632-1646 [Abstract] [Full Text]  
• White, R. L (1998). Thrombolytic Therapy in Acute Myocardial Infarction Part II: 1997 Update. Asian Cardiovasc. Thorac. Ann. 6: 03-10 [Abstract] [Full Text]  
• Collins, R., Peto, R., Baigent, C., Sleight, P. (1997). Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction. NEJM 336: 847-860 [Full Text]  
• Dorman, P. J., Sandercock, P. A.G. (1996). Considerations in the Design of Clinical Trials of Neuroprotective Therapy in Acute Stroke. Stroke 27: 1507-1515 [Full Text]  
• French, J. K, Williams, B. F, Hart, H. H, Wyatt, S., Poole, J. E, Ingram, C., Ellis, C. J, Williams, M. G, White, H. D (1996). Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. BMJ 312: 1637-1641 [Abstract] [Full Text]  
• Hussain, K.M.A., Gould, L., Sosler, B., Bharathan, T., Reddy, C.V.R. (1996). Clinical Science Review: Current Aspects of Thrombolytic Therapy in Women with Acute Myocardial Infarction. ANGIOLOGY 47: 23-33 [Abstract]  
• Raitt, M. H., Maynard, C., Wagner, G. S., Cerqueira, M. D., Selvester, R. H., Weaver, W. D. (1996). Relation Between Symptom Duration Before Thrombolytic Therapy and Final Myocardial Infarct Size. Circulation 93: 48-53 [Abstract] [Full Text]  
• Neuhaus, K.-L. (1995). More on Thrombolysis and Hemorrhagic Stroke. Circulation 92: 2794-2795 [Full Text]  
• Benedict, C. R., Refino, C. J., Keyt, B. A., Pakala, R., Paoni, N. F., Thomas, G. R., Bennett, W. F. (1995). New Variant of Human Tissue Plasminogen Activator (TPA) With Enhanced Efficacy and Lower Incidence of Bleeding Compared With Recombinant Human TPA. Circulation 92: 3032-3040 [Abstract] [Full Text]  
• Kellett, J., Clarke, J. (1995). Comparison of "Accelerated" Tissue Plasminogen Activator with Streptokinase for Treatment of Suspected Myocardial Infarction. Med Decis Making 15: 297-310 [Abstract]  
• Lenderink, T., Simoons, M. L., Van Es, G.-A., Van de Werf, F., Verstraete, M., Arnold, A. E.R. (1995). Benefit of Thrombolytic Therapy Is Sustained Throughout Five Years and Is Related to TIMI Perfusion Grade 3 But Not Grade 2 Flow at Discharge. Circulation 92: 1110-1116 [Abstract] [Full Text]  
• Terada, Y., Mitsui, T., Matsushita, S., Atsumi, N., Jikuya, T., Sakakibara, Y. (1995). Influence of Bypass Grafting to the Infarct Artery on Late Potentials in Coronary Operations. Ann. Thorac. Surg. 60: 422-425 [Abstract] [Full Text]  
• Van de Werf, F. (1995). Thrombolysis for Acute Myocardial Infarction : Why Is There No Extra Benefit After Hospital Discharge?. Circulation 91: 2862-2864 [Full Text]  
• Ono, S., Waldman, L. K., Yamashita, H., Covell, J. W., Ross, J. Jr (1995). Effect of Coronary Artery Reperfusion on Transmural Myocardial Remodeling in Dogs. Circulation 91: 1143-1153 [Abstract] [Full Text]  
• Salem, B. I., Lagos, J. A., Haikal, M., Gowda, S. (1994). The Potential Impact of the Thrombolytic Era on Cardiac Rupture Complicating Acute Myocardial Infarction. ANGIOLOGY 45: 931-936 [Abstract]  
• Fendrick, A. M., Ridker, P. M., Bloom, B. S. (1994). Improved Health Benefits of Increased Use of Thrombolytic Therapy. Arch Intern Med 154: 1605-1609 [Abstract]  
• Midgette, A. S., Wong, J. B., Beshansky, J. R., Porath, A., Fleming, C., Pauker, S. G. (1994). Cost - Effectiueness of Streptokinase for Acute Myocardial Infarction: A Combined Meta-analysis and Decision Analysis of the Effects of Infarct Location and of Likelihood of Infarction. Med Decis Making 14: 108-117 [Abstract]  
• The European Myocardial Infarction Project Group, (1993). Prehospital Thrombolytic Therapy in Patients with Suspected Acute Myocardial Infarction. NEJM 329: 383-389 [Abstract] [Full Text]  
• Gibbons, R. J., Holmes, D. R., Reeder, G. S., Bailey, K. R., Hopfenspirger, M. R., Gersh, B. J., The Mayo Coronary Care Unit and Catheterization La, (1993). Immediate Angioplasty Compared with the Administration of a Thrombolytic Agent Followed by Conservative Treatment for Myocardial Infarction. NEJM 328: 685-691 [Abstract] [Full Text]  
• Pagley, P. R., Yarzebski, J., Goldberg, R., Chen, Z., Chiriboga, D., Dalen, P., Gurwitz, J., Alpert, J. S., Gore, J. M. (1993). Gender Differences in the Treatment of Patients With Acute Myocardial Infarction: A Multihospital, Community-Based Perspective. Arch Intern Med 153: 625-629 [Abstract]  
• Eckman, M. H., Wong, J. B., Salem, D. N., Pauker, S. G. (1992). Direct Angioplasty for Acute Myocardial Infarction: A Review of Outcomes in Clinical Subsets. ANN INTERN MED 117: 667-676 [Abstract]  
• Hamouratidis, N., Katsaliakis, N., Manoudis, F., Lazaridis, K., Tselegaridis, T., Stravelas, V., Simeonidou, E., Roussis, S. (1991). Early Exercise Test in Acute Myocardial Infarction Treated with Intravenous Streptokinase. ANGIOLOGY 42: 696-702 [Abstract]  
• Bovill, E. G., Terrin, M. L., Stump, D. C., Berke, A. D., Frederick, M., Collen, D., Feit, F., Gore, J. M., Hillis, L. D., Lambrew, C. T., Leiboff, R., Mann, K. G., Markis, J. E., Pratt, C. M., Sharkey, S. W., Sopko, G., Tracy, R. P., Chesebro, J. H. (1991). Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. ANN INTERN MED 115: 256-265 [Abstract]  
• Cragg, D. R., Friedman, H. Z., Bonema, J. D., Jaiyesimi, I. A., Ramos, R. G., Timmis, G. C., O'Neill, W. W., Schreiber, T. L. (1991). Outcome of Patients with Acute Myocardial Infarction Who Are Ineligible for Thrombolytic Therapy. ANN INTERN MED 115: 173-177 [Abstract]  
• Midgette, A. S., O'Connor, G. T., Baron, J. A., Bell, J. (1990). Effect of Intravenous Streptokinase on Early Mortality in Patients with Suspected Acute Myocardial Infarction: A Meta-Analysis by Anatomic Location of Infarction. ANN INTERN MED 113: 961-968 [Abstract]  
• Naylor, C. D., Jaglal, S. B. (1990). Impact of Intravenous Thrombolysis on Short-term Coronary Revascularization Rates: A Meta-analysis. JAMA 264: 697-702 [Abstract]  
• Collen, D. (1990). Coronary Thrombolysis: Streptokinase or Recombinant Tissue-Type Plasminogen Activator?. ANN INTERN MED 112: 529-538 [Abstract]  
• Ovsyshcher, I., Silber, H., Hausman, M.I., Margolis, G., Gueron, M. (1990). Improved Left Ventricular Function in Myocardial Infarction Following Intravenous Thrombolytic Therapy with Acylated Plasminogen Activator. ANGIOLOGY 41: 133-138 [Abstract]  
• Krichbaum, D. W., Trivedi, D. A. (1990). Thrombolytic Therapy in Acute Myocardial Infarction. Journal of Pharmacy Practice 3: 332-348  
• Babalis, D. C., Boutos, G. N., Iliodromitis, E. K., Trovas, A. K., Vorides, E. M. (1989). Precordial ECG Mapping in Acute Myocardial Infarction (AMI) After Intravenous Infusion of Streptokinase (s). ANGIOLOGY 40: 1040-1047 [Abstract]  
• Jayes, R. L. (1989). Emergency Room Patients, Chest Pain, and Thrombolysis. ANN INTERN MED 111: 685-686 [Abstract]  
• Detsky, A. S. (1989). Are Clinical Trials a Cost-effective Investment?. JAMA 262: 1795-1800 [Abstract]  
• Rowe, W. W., Simpson, R. J. Jr, Tate, D. A., Willis, P. W. IV, Nichols, T. C., Noneman, J. W., Gettes, L. S. (1989). Nonemergent Cardiac Catheterization and Risk-Stratified Revascularization Following Thrombolytic Therapy for Acute Myocardial Infarction: A Critical Analysis of Therapy in the Community Setting. Arch Intern Med 149: 1611-1617 [Abstract]  
• Lee, T. H., Weisberg, M. C., Brand, D. A., Rouan, G. W., Goldman, L. (1989). Candidates for Thrombolysis among Emergency Room Patients with Acute Chest Pain: Potential True- and False-Positive Rates. ANN INTERN MED 110: 957-962 [Abstract]  
• Haber, E, Quertermous, T, Matsueda, G., Runge, M. (1989). Innovative approaches to plasminogen activator therapy. Science 243: 51-56 [Abstract]  
• Topol, E. J. (1988). Coronary Angioplasty for Acute Myocardial Infarction. ANN INTERN MED 109: 970-980 [Abstract]  
• Kowey, P. R., Fisher, L., Giardina, E.-G., Leier, C. V., Lowenthal, D. T., Messerli, F. H., Pratt, C. M. (1988). The TPA Controversy and the Drug Approval Process: The View of the Cardiovascular and Renal Drugs Advisory Committee. JAMA 260: 2250-2252 [Abstract]  
• Yusuf, S., Wittes, J., Friedman, L. (1988). Overview of Results of Randomized Clinical Trials in Heart Disease: I. Treatments Following Myocardial Infarction. JAMA 260: 2088-2093 [Abstract]  
• CALIFF, R. M., O'NEIL, W., STACK, R. S., ARONSON, L., MARK, D. B., MANTELL, S., GEORGE, B. S., CANDELA, R. J., KEREIAKES, D. J., ABBOTTSMITH, C., TOPOL, E. J., TAMI Study Group, (1988). Failure of Simple Clinical Measurements to Predict Perfusion Status after Intravenous Thrombolysis. ANN INTERN MED 108: 658-662 [Abstract]  
• May, K. J. Jr, Cardone, J. T., Stroebel, P. P., Riba, A. L. (1988). Streptokinase Dissolution of a Right Atrial Thrombus Associated With a Temporary Pacemaker. Arch Intern Med 148: 903-904 [Abstract]  
• Salem, B. I., Gowda, S., Haikal, M. (1987). Reduced In-Hospital Mortality Following Intracoronary Streptokinase Treatment of Acute Myocardial Infarction. VASC ENDOVASCULAR SURG 21: 215-219 [Abstract]